APA (7th ed.) Citation

FS, F. (2023). Small-interfering RNA targeting proprotein convertase subtilisin/kexin type 9 might promote fatty liver disease and hepatocellular carcinoma through upregulation of CD36. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 45(1), 73. https://doi.org/10.3233/TUB-230007

Chicago Style (17th ed.) Citation

FS, Fan. "Small-interfering RNA Targeting Proprotein Convertase Subtilisin/kexin Type 9 Might Promote Fatty Liver Disease and Hepatocellular Carcinoma Through Upregulation of CD36." Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 45, no. 1 (2023): 73. https://doi.org/10.3233/TUB-230007.

MLA (9th ed.) Citation

FS, Fan. "Small-interfering RNA Targeting Proprotein Convertase Subtilisin/kexin Type 9 Might Promote Fatty Liver Disease and Hepatocellular Carcinoma Through Upregulation of CD36." Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 45, no. 1, 2023, p. 73, https://doi.org/10.3233/TUB-230007.